Biogen (BIIB) Stock: Revenue, Earnings, Margins & Valuation
Biogen share price
| Price (USD) | 253.62 |
|---|---|
| Price date | 2026-10-31 |
| Market capitalization | 37.44 USD bn |
Annual and quarterly filings: SEC EDGAR – Biogen
Biogen (BIIB), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report, visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Biogen business model
The income statement of Biogen is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
Sector: Health Care
More stock analyses like Biogen
- Boston Scientific stock (BSX)
- Bristol Myers Squibb stock (BMY)
- Cardinal Health stock (CAH)
- Cencora stock (COR)
- BlackRock Inc. stock (BLK)
- Bio-Techne stock (TECH)
- Blackstone Inc. stock (BX)
- Best Buy stock (BBY)